Litigation Details for Novartis Pharmaceuticals Corporation v. Actavis Inc. (D. Del. 2015)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Actavis Inc. (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-12-29 |
Court | District Court, D. Delaware | Date Terminated | 2017-09-18 |
Cause | 35:0145 | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,465,504 | ||
Firms | Richards, Layton & Finger, PA | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Actavis Inc.
Details for Novartis Pharmaceuticals Corporation v. Actavis Inc. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-09-18 | 123 | Order | before the expiration of U.S. Patent No. 6,465,504 (the "'504 Patent") on the basis that …that certain claims of the '504 Patent are allegedly invalid or will allegedly not be infringed by…IV Certification with respect to the '504 Patent in ANDA No. 208697 and replaced it with a certification…Tablets prior to the expiration of the '504 Patent. 3. Defendants hereby affirm that… IV Certification with respect to the '504 Patent unless and until MEl 25677793v.1 Case 1:15-cv | External link to document |
2017-09-19 | 124 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504. (Attachments: # 1 … 18 September 2017 1:15-cv-01219 830 Patent None District Court, D. Delaware | External link to document |
2015-12-29 | 4 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number: 6,465,504. (klc) (Entered: 12/… 18 September 2017 1:15-cv-01219 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |